Help Us Study a New Treatment Option for OCD

Would you like to take part in a clinical trial for a new investigational medication for people suffering with OCD?

Why Join Us

We need your help in our mission to successfully develop the first new medication for OCD since the mid-1990s.

You will receive study-related care and evaluations of your OCD-related symptoms at no cost to you (no insurance required).

You may receive compensation for time and travel to attend study visits.

The Process to See If You Qualify

If you have been diagnosed with OCD, or think you may have symptoms, are between 18 & 65 years of age, and are not taking the SSRI medication: Fluvoxamine (Luvox), please take the next 3 steps below: 

Select the clinic that is most convenient for you.

Use the provided information to call or email the clinic.

Study clinicians will assess your eligibility, and discuss possible next steps.

Call or email the nearest clinic below for more information.

MAC Clinical Research – Lancashire

Kaman Court, 1 Faraday Way

Blackpool, FY2 0JH

Ellice Partington, Study Coordinator

01253 444 451

Greater Manchester Mental Health NHS Foundation Trust

3rd Floor, Rawnsley Building, Hathersage Road

Manchester, M13 9WL

Leanne Howieson, Study Coordinator

0161 358 7583

MAC Clinical Research – Greater Manchester

Neuroscience Centre of Excellence, Citylabs, Nelson Street

Manchester, M13 9NQ

Sukoluhle Mguni, Site Director

0161 275 9966

MAC Clinical Research – Merseyside

11 Tiger Court, Kings Drive, King’s Business Park, Prescot

Merseyside, L34 1BH

Grace Austin, Study Coordinator

0151 482 4700

Bioluminux Ltd.

15 Diamond Court, Opal Drive, Fox Milne

Milton Keynes, MK15 0DU

Orsolya Lawrence, Director of Clinical Operations and Business Development

01908 985 540

Stemax Consult Healthcare Services Ltd

Unit F, Old Stratford Business Park, Falcon Drive, Off Stony Stratford Road Northamptonshire, MK19 6FG

Olu bunmi Ijeh, Site Director
01908 032 992

Cornwall Partnership NHS Foundation Trust

The Kernow Building, Wilson Way, Pool
Redruth, TR15 3QE

Richard Higgins, Senior Research Nurse
01209 204020

MAC Clinical Research – Stockton-on-Tees

GAC House, Sabatier Close

Stockton-on-Tees, TS17 6EW

Jessica Regan, Study Coordinator

01642 853 540

MAC Clinical Research – South Staffordshire

Exchange House, Watling Street – Cannock

South Staffordshire, WS11 0BN

Alice Allen, Study Coordinator

01543 501 212

MAC Clinical Research – South Yorkshire

Phoenix House, Maple Road
Tankersley, S75 3DL

Jodie Lanceley, Study Coordinator

01226 356 940

MAC Clinical Research – Leeds

Monarch House, Wakefield Road, Leeds

Yorkshire, LS10 1DU

Ryan Williams, Study Coordinator

0113 272 8910

About Biohaven

Biohaven Pharmaceuticals in New Haven, Connecticut, is the sponsor of the study. Biohaven researches a range of neurological and neurobiological disorders, and obsessive-compulsive disorder is an important focus of their work.